A study protocol: A community pharmacy-based intervention for improving the management of sleep disorders in the community settings

BMC Health Services Research

Volumn 14, Issue , 2014, Pages

  Mohamad Noor, Zaswiza ^a,c   Smith, Alesha J ^a,d   Smith, Simon S ^b   Nissen, Lisa M ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA   (Malaysia)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Actigraphy; Community pharmacy; Sleep disorders

Indexed keywords

EID: 84894613620     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-14-74     Document Type: Article

References (56)

1. Breathe Easily, Sleep Well: World Sleep Day Promotes Healthy, Undisturbed Sleep. http://www.worldsleepday.org/press-release/ ], Accessed 12 June 2012
2. Health screening in community pharmacy: an update. Jackson S, Peterson G, Pharm 2006 25 846 851
3. Rural pharmacist perceptions of a project assessing role in the management of depression. Crockett J, Taylor S, Aust J Rural Health 2009 17 236 243 10.1111/j.1440-1584.2009.01084.x 19785675
4. Perceived feasibility of a community pharmacy-based asthma intervention: a qualitative follow-up study. Bereznicki B, Peterson G, Jackson S, Haydn Walters E, DeBoos I, Hintz P, J Clin Pharm Ther 2011 36 348 355 10.1111/j.1365-2710.2010.01187.x 21545614
5. Treating asthma with a self-management model of illness behaviour in an Australian community pharmacy setting. Smith L, Bosnic-Anticevich SZ, Mitchell B, Saini B, Krass I, Armour C, Soc Sci Med 2007 64 1501 1511 10.1016/j.socscimed.2006.11.006 17202024 (Pubitemid 46349380)
6. Development, implementation, and evaluation of a community pharmacy-based asthma care model. Saini B, Krass I, Armour C, Ann Pharmacother 2004 38 1954 1960 10.1345/aph.1E045 15479780 (Pubitemid 39425733)
7. Asthma management by New Zealand pharmacists: a pharmaceutical care demonstration project. Emmerton L, Shaw J, Kheir N, J Clin Pharm Ther 2003 28 395 402 10.1046/j.0269-4727.2003.00507.x 14632964 (Pubitemid 37352449)
8. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Armour C, Bosnic-Anticevich S, Brillant M, Burton D, Emmerton L, Krass I, Saini B, Smith L, Steward K, Thorax 2007 62 496 502 10.1136/thx.2006.064709 17251316 (Pubitemid 46910127)
9. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. Machado M, Bajcar J, Guzzo GC, Einarson TR, Ann Pharmacother 2007 41 1569 1582 10.1345/aph.1K151 17712043 (Pubitemid 47479786)
10. Managing diabetes: special patient groups: role of the C.D.E. Steil C, US Pharm 1989 14 suppl 5 6 8, 10
11. Community pharmacist-provided extended diabetes care. Doucette WR, Witry MJ, Farris KB, McDonough RP, Ann Pharmacother 2009 43 882 889 10.1345/aph.1L605 19401477
12. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). McLean DL, McAlister FA, Johnson JA, King KM, Makowsky MJ, Jones CA, Tsuyuki RT, SCRIP-HTN Investigators, Arch Intern Med 2008 168 2355 2361 10.1001/archinte.168.21.2355 19029501
13. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Machado M, Bajcar J, Guzzo GC, Einarson TR, Ann Pharmacother 2007 41 1770 1781 10.1345/aph.1K311 17925496 (Pubitemid 350044338)
14. Wake Up Australia: The Value Of Healthy Sleep. http://www.sleep.org.au/ documents/item/69 ], Accessed 10 Feb 2012
15. The economic cost of sleep disorders. Hillman DR, Murphy AS, Antic R, Pezzulo L, SLEEP 2006 29 299 305 16553015 (Pubitemid 44019952)
16. A survey of sleeping difficulties in an Australian population. Lack L, Miller W, Turner D, Community Health Stud 1988 12 200 207 3262036
17. Unilateral periorbital swelling with nasal CPAP therapy. Ely JR, Khorfan F, J Clin Sleep Med 2006 2 330 331 17561548 (Pubitemid 44299560)
18. Effects of continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea in arterial stiffness: a meta-analysis. Vlachantoni IT, Dikaiakou E, Antonopoulos CN, Stefanadis C, Daskalopoulou SS, Petridou ET, Sleep Med Rev 2012 doi:10.1016/j.smrv.2012.01.002
19. National Institutes of Health State of the Science Conference statement on manifestations and management of chronic insomnia in adults, June 13-15, 2005. National Institutes of Health, SLEEP 2005 28 1049 1058 16268373
20. Clinical guideline for the evaluation and management of chronic insomnia in adults. Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M, J Clin Sleep Med 2008 4 487 504 18853708
21. Acceptance and long-term compliance of nCPAP in obstructive sleep apnea. Richard W, Venker J, Den Herder C, Kox D, Van den Berg B, Laman M, Van Tinteren H, De Vries N, Eur Arch Otorhinolaryngol 2007 264 1081 86 10.1007/s00405-007- 0311-3 17443336 (Pubitemid 47106828)
22. How do pharmacists respond to complaints of acute insomnia? A simulated patient study. Kippist C, Wong K, Bartlett D, Saini B, Int J Clin Pharm 2011 33 237 45 10.1007/s11096-011-9482-5 21394573
23. Nonprescription treatments of snoring or obstructive sleep apnea: an evaluation of products with limited scientific evidence. Report of the Clinical Practice Review Committee, American Academy of Sleep Medicine, SLEEP 2003 26 619 24 12938818
24. The development of a sleep disorder screening program in Australia community pharmacy. Tran A, Fuller JM, Wong KK, Krass I, Grunstein R, Saini B, Pharm World Sci 2009 31 473 80 10.1007/s11096-009-9301-4 19462256
25. Screening for sleep disorders in community pharmacies-evaluation of a campaign in Switzerland. Hersberger KE, Renggli VP, Nirkko AC, Mathis J, Schwegler K, Bloch KE, J Clinical Pharmacy and Therapeutics 2006 31 35 41 10.1111/j.1365-2710.2006.00698.x
26. Sleep and wakefulness disturbances in Swiss pharmacy customers. Schwegler K, Klaghofer R, Nirkko AC, Mathis J, Hersberger KE, Bloch KE, Swiss Med Weekly 2006 136 149 54
27. Sleep disorders screening, sleep health awareness, and patient follow-up by community pharmacists in Australia. Fuller JM, Wong KK, Krass I, Grunstein R, Saini B, Patient Educ Couns 2011 83 325 35 10.1016/j.pec.2011.05.004 21640541
28. Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. Standards of Practice Committee of the American Academy of Sleep Medicine, SLEEP 2007 30 519 29 17520797
29. Practice parameters for the role of actigraphy in the study of sleep and circadian rhythms: an update for 2002. Standards of Practice Committee of the American Academy of Sleep Medicine, SLEEP 2003 26 337 41 12749556
30. Comparison between subjective and actigraphic measurement of sleep and sleep rhythms. Lockley SW, Skene DJ, Arendt J, J Sleep Res 1999 8 175 83 10.1046/j.1365-2869.1999.00155.x 10476003 (Pubitemid 29433608)
31. Actigraphy in the assessment of insomnia. Vallieres A, Morin CM, SLEEP 2003 26 902 6 14655927 (Pubitemid 39610639)
32. The role of actigraphy in the study of sleep and circadian rhythms. Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP, SLEEP 2003 26 342 92 12749557 (Pubitemid 39610685)
33. Further validation of actigraphy for sleep studies. De Souza L, Benedito-Silva AA, Pires ML, Poyares D, Tufik S, Calil HM, SLEEP 2003 26 81 85 12627737
34. Comparison of actigraphic, polysomnographic, and subjective assessment of sleep parameters in sleep-disordered patients. Kushida CA, Chang A, Gadkary C, Guilleminault C, Carillo O, Dement WC, Sleep Med 2001 2 389 96 10.1016/S1389-9457(00)00098-8 14592388 (Pubitemid 32952342)
35. Feasibility and acceptability of wrist actigraph in assessing sleep quality and sleep quantity: a home-based pilot study in healthy volunteers. Noor ZM, Smith AJ, Smith SS, Nissen LM, Health 2013 5 63 72 10.4236/health.2013. 58A2010
36. Assessment and counselling provided with over-the-counter sleep request: a secret shopper study. Prakash K, Nissen L, Smith S, Kyle G, In proceedings of the Australasian Pharmaceutical Sciences Association annual conference (APSA) Adelaide 11-14 December 2011
37. A novel adaptive wrist actigraphy algorithm for sleep-wake assessment in sleep apnea patients. Hedner J, Pillar G, Pittman SD, Zou D, Grote L, White DP, SLEEP 2004 27 1560 66 15683148 (Pubitemid 40041626)
38. Interpreting wrist actigraphic indices of sleep in epidemiologic studies of the elderly: the study of osteoporotic fractures. Mehra R, Stone KL, Ancoli-Israel S, Litwack-Harisson S, Ensrud KE, Redline S, SLEEP 2008 31 1569 76 19014077
39. Actigraphy validation with insomnia. Lichstein KL, Stone KC, Donaldson J, Nau SD, Soeffing JP, Murray D, Lester KW, Neil Aguillard R, SLEEP 2006 29 232 39 16494091 (Pubitemid 44019977)
40. Comparison of actigraphy with polysomnography and sleep logs in depressed insomniacs. Mccall C, Vaughn Mccall W, J Sleep Res 2012 21 122 27 10.1111/j.1365-2869.2011.00917.x 21447050
41. Objective and subjective assessment in chronic low back pain patients compared with healthy age and gender matched controls: a pilot study. O'Donoghue GM, Fox N, Heneghan C, Hurley DA, BMC Musculoskelet Disord 2009 10 122 10.1186/1471-2474-10-122 10.1186/1471-2474-10-122 19799778
42. Mindfulness-based stress reduction vs. Pharmacotherapy for primary chronic insomnia: a pilot randomized controlled clinical trial. Gross CR, Kreitzer MJ, Reilly-Spong M, Wall M, Winbush NY, Patterson R, Mahowald M, Cramer-Bornemann M, Explore (NY) 2011 7 76 87 10.1016/j.explore.2010.12.003 21397868
43. Sleep Right Sleep Tight: Sleep Diary. http://www.nps.org.au/topics/sleep- campaign/resources/sleep-diary ], Accessed 6 Feb 2012
44. Sleep Study Report. http://sleepapneafaq.wikispaces.com/ Sleep+Study+report ], Accessed 9 July 2012
45. The Pharmaceutical Society of Australia, Professional Practice Standards Version 4 2010 Canberra: The Pharmaceutical Society of Australia 2010
46. WHO-5 Well Being Index. http://cure4you.dk/354/WHO-5-English.pdf ], Accessed 12 June 2012
47. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes. Wade AG, Ford I, Crawford G, McMahon AD, Nir T, Laudon M, Zisapel N, Curr Med Res Opin 2007 23 2597 605 10.1185/030079907X233098 17875243 (Pubitemid 350033462)
48. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Johns MW, SLEEP 1991 14 540 45 1798888
49. Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth sleepiness scale. Johns MW, Chest 1993 103 30 6 10.1378/chest.103.1.30 8417909 (Pubitemid 23027228)
50. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Bastien CH, Vallières A, Morin CM, Sleep Med 2001 2 297 307 10.1016/S1389-9457(00)00065-4 11438246 (Pubitemid 32677404)
51. A survey screen for prediction of apnea. Maislin G, Pack AI, Kribbs NB, Smith PL, Schwartz AR, Kline LR, Schwab RJ, Dinges DF, SLEEP 1995 18 58 66 7761745
52. Validation of the international restless legs syndrome study group rating scale for the restless legs syndrome. Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, Trenkwalder C, Sleep Med 2003 4 121 32 14592342 (Pubitemid 36527232)
53. IBM SPSS Statistics 20 Documentation. http://www-01.ibm.com/support/ docview.wss?uid=swg27021213#en ], Accessed 12 June 2012
54. Colten HR, Altevogt BM, Sleep Disorders And Sleep Deprivation: An Unmet Public Health Problem Washington DC: The National Academic Press 2006
55. Pandi-Perumal SR, Leger D, Sleep Disorders: Their Impact On Public Health Oxon: Informa Healthcare 2006
56. Re-Awakening Australia: The Economic Cost Of Sleep Disorders In Australia, 2010. http://www.sleephealthfoundation.org.au/pdfs/news/ Reawakening%20Australia.pdf ], Accessed 9 July 2012